Key result
In a rat model of acute myocardial infarction, Buckberg blood cardioplegia significantly improved recovery of left ventricular developed pressure compared to Bretschneider crystalloid cardioplegia (54% vs 9%, p=0.0062).
Why the study?
Because hearts in acute myocardial infarction are prone to ischemia-reperfusion damage during cardiac surgery, the influence of crystalloid versus blood cardioplegia solutions needed investigation.
Does extracellular blood cardioplegia improve myocardial recovery and reduce infarct size compared to intracellular crystalloid cardioplegia in a rat model of acute myocardial infarction?
Does extracellular blood cardioplegia improve myocardial recovery and reduce infarct size compared to intracellular crystalloid cardioplegia in a rat model of acute myocardial infarction?
Absolute Event Rate: 54% vs 9%
p-value: p=0.0062
In a rat model of acute myocardial infarction, blood cardioplegia leads to better myocardial functional recovery and smaller infarct size compared to crystalloid cardioplegia.
Supports blood cardioplegia in experimental ischemia; leaves open clinical validation in humans.
BACKGROUND: Because hearts in acute myocardial infarction are often prone to ischemia-reperfusion damage during cardiac surgery, we investigated the influence of intracellular crystalloid cardioplegia solution (CCP) and extracellular blood cardioplegia solution (BCP) on cardiac function, metabolism, and infarct size in a rat heart model of myocardial infarction. METHODS: Following euthanasia, the hearts of 50 rats were quickly excised, cannulated, and inserted into a blood-perfused isolated heart apparatus. A regional myocardial infarction was created in the infarction group (18 hearts) for 120 min; the control group (32 hearts) was not subjected to infarction. In each group, either Buckberg BCP or Bretschneider CCP was administered for an aortic clamping time of 90 min. Functional parameters were recorded during reperfusion: coronary blood flow, left ventricular developed pressure (LVDP) and contractility (dp/dt max). Infarct size was determined by planimetry. The results were compared between the groups using analysis of variance or parametric tests, as appropriate. RESULTS: Cardiac function after acute myocardial infarction, 90 min of cardioplegic arrest, and 90 min of reperfusion was better preserved with Buckberg BCP than with Bretschneider CCP relative to baseline (BL) values (LVDP 54 ± 11% vs. 9 ± 2.9% [p = 0.0062]; dp/dt max. 73 ± 11% vs. 23 ± 2.7% [p = 0.0001]), whereas coronary flow was similarly impaired (BCP 55 ± 15%, CCP 63 ± 17% [p = 0.99]). The infarct in BCP-treated hearts was smaller (25% of myocardium) and limited to the area of coronary artery ligation, whereas in CCP hearts the infarct was larger (48% of myocardium; p = 0.029) and myocardial necrosis was distributed unevenly to the left ventricular wall. CONCLUSIONS: In a rat model of acute myocardial infarction followed by cardioplegic arrest, application of BCP leads to better myocardial recovery than CCP.
No takes yet. Share an insight, caveat, or question.
Boening et al. (2020) studied Acute myocardial infarction (experimental rat model) (n=50). Buckberg blood cardioplegia (BCP) vs. Bretschneider crystalloid cardioplegia (CCP) was evaluated on Recovery of left ventricular developed pressure (LVDP) relative to baseline (p=0.0062). In a rat model of acute myocardial infarction, Buckberg blood cardioplegia significantly improved recovery of left ventricular developed pressure compared to Bretschneider crystalloid cardioplegia (54% vs 9%, p=0.0062).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: